Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Institutional Investor > Royalty Pharma Sub-manager, Llc > Profile

Instuitional Investor - Royalty Pharma Sub-manager, Llc

Profile
13F Holdings

Fund Profile

Filing Period:

Fund Name:	Royalty Pharma Sub-manager, Llc
Portfolio Value	$171,312,250

Top 13F Holdings

Filing Period:

No.	Security	Ticker	Shares	Value	% Port
1.	Cytokinetics Inc	CYTK	980,392	$62,294,108	36.36%
2.	Bicara Therapeutics Inc.	BCAX	1,263,150	$45,864,977	26.77%
3.	Biohaven Ltd.	BHVN	2,936,507	$33,153,164	19.35%
4.	Biocryst Pharmaceuticals Inc	BCRX	3,846,154	$30,000,001	17.51%